ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0847

A Psychometric Analysis of the Self-Efficacy for Managing Chronic Disease Scale in Systemic Sclerosis: A Scleroderma Patient-Centered Intervention Network Cohort Study

Alyssa Choi1, Chelsea Rapoport2, Linda Kwakkenbos3, Marie-Eve Carrier4, Karen Gottesman5, Scott Roesch6, Brett Thombs7 and Vanessa Malcarne6, 1SDSU/UC San Diego Joint Doctoral Program in Clinical Psychology, San Diego, CA, 2SDSU/UC San Diego Joint Doctoral Program in Clinical Psychology, La Jolla, CA, 3Department of Clinical Psychology, Radboud University Behavioural Science Institute, Nijmegen, Netherlands, 4Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, QC, Canada, 5Scleroderma Foundation, Southern California Chapter, Danvers, MA, 6SDSU/UC San Diego Joint Doctoral Program in Clinical Psychology; Department of Psychology, San Diego State University, San Diego, CA, 7Lady Davis Institute for Medical Research, Jewish General Hospital; Department of Psychiatry, McGill University, Montréal, QC, Canada

Meeting: ACR Convergence 2021

Keywords: Measurement, psychosocial factors, Systemic sclerosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 7, 2021

Title: Research Methodology Poster (0846–0854)

Session Type: Poster Session B

Session Time: 8:30AM-10:30AM

Background/Purpose: Self-efficacy is a key determinant of health behaviors and the target mechanism of self-management programs for patients with chronic diseases. The Self-Efficacy for Managing Chronic Disease (SEMCD) scale, a brief self-report instrument, has been widely used to measure self-efficacy in chronic disease populations and is validated in English for use in people with systemic sclerosis (SSc). However, it is essential that translations of measures be examined for psychometric equivalence across populations, and no research has yet ascertained that SEMCD scores are comparable across languages. The present study examined the cross-language measurement equivalence of the SEMCD in a sample of English- or French-speaking adults with SSc.

Methods: Adults with SSc (N = 2159; 87.4% female; 57.3% limited SSc; 68.3% English-speaking) from 46 centers were enrolled in the Scleroderma Patient-Centered Intervention Network (SPIN) Cohort. All participants were classified as having SSc according to the 2013 ACR/EULAR classification criteria. The SEMCD scale includes 6 items and higher scores indicate higher levels of self-efficacy. Confirmatory factor analysis (CFA) was used to confirm the single-factor structure of the SEMCD scale. Cronbach’s coefficient alpha and McDonald’s omega were used to evaluate internal consistency reliability. Multiple group confirmatory factor analysis (MGCFA) was used to determine whether the single-factor structure was supported in both languages. The Multiple-Indicator Multiple-Cause (MIMIC) model was used to examine differential item functioning (DIF).

Results: The mean total score on the SEMCD was 6.45 (SD = 2.26, range = 1-10). The SEMCD demonstrated good internal consistency reliability (α = .93, ω = .93). CFA indicated that a one-factor model fit well based on 2 of the 3 tested indices of model fit (Comparative Fit Index [CFI] = .96, Standardized Root Mean Residual [SRMR] = .03). The Root Mean Square Error of Approximation (RMSEA) indicated less than acceptable model fit (RMSEA = .14). Standardized factor loadings for all items were large and statistically significant (all ps < .001; range .755 to .879). Results from the MGCFA supported the metric invariance model as the best fit for the data (Δχ2 [10, N = 2159] = 13.32, p = .206), suggesting that the factor loadings are invariant across English and French language versions. The overall MIMIC model fit well and indicated that the SEMCD items demonstrate cross-language metric equivalence (CFI = .96, SRMR = .03, RMSEA = .12), although a statistically significant but small-magnitude DIF was found for one SEMCD item across language (β = .03, p < .05).

Conclusion: Findings support the use of the SEMCD as a reliable and valid single-factor measure of self-efficacy in SSc. SEMCD scores from English- and French-speaking individuals with SSc can be compared or combined for analysis. Future studies should examine the metric equivalence of the SEMCD across other linguistic and sociodemographic groups (e.g., race/ethnicity, sex).


Disclosures: A. Choi, None; C. Rapoport, None; L. Kwakkenbos, None; M. Carrier, None; K. Gottesman, None; S. Roesch, None; B. Thombs, None; V. Malcarne, None.

To cite this abstract in AMA style:

Choi A, Rapoport C, Kwakkenbos L, Carrier M, Gottesman K, Roesch S, Thombs B, Malcarne V. A Psychometric Analysis of the Self-Efficacy for Managing Chronic Disease Scale in Systemic Sclerosis: A Scleroderma Patient-Centered Intervention Network Cohort Study [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/a-psychometric-analysis-of-the-self-efficacy-for-managing-chronic-disease-scale-in-systemic-sclerosis-a-scleroderma-patient-centered-intervention-network-cohort-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-psychometric-analysis-of-the-self-efficacy-for-managing-chronic-disease-scale-in-systemic-sclerosis-a-scleroderma-patient-centered-intervention-network-cohort-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology